What is the most current recommendation for the treatment of latent tuberculosis?

Fuente: Zenodo
Enregistré dans:
Détails bibliographiques
Auteur principal: Tripdatabase
Format: Recurso digital
Publié: Zenodo 2026
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1866901257235464192
author Tripdatabase
author_facet Tripdatabase
contents Multiple regimens are recommended for LTBI treatment, including 3-month regimens of isoniazid and rifapentine or rifampicin, and 6 to 9 months of isoniazid, depending on patient risk and adherence considerations.
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_19254534
institution Zenodo
language
publishDate 2026
publisher Zenodo
record_format zenodo
spellingShingle What is the most current recommendation for the treatment of latent tuberculosis?
Tripdatabase
latent tuberculosis
treatment
recommendation
infectious diseases
public health
Multiple regimens are recommended for LTBI treatment, including 3-month regimens of isoniazid and rifapentine or rifampicin, and 6 to 9 months of isoniazid, depending on patient risk and adherence considerations.
title What is the most current recommendation for the treatment of latent tuberculosis?
topic latent tuberculosis
treatment
recommendation
infectious diseases
public health
url https://doi.org/10.5281/zenodo.19254534